Avapritinib Maintenance for AML With KIT Mutations
NCT06765915
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
47
Enrollment
OTHER
Sponsor class
Conditions
AML, Adult
Interventions
DRUG:
Avapritinib
Sponsor
Ruijin Hospital